Chemiluminescent Optical Fiber Immunosensor Combining Surface Modification and Signal Amplification for Ultrasensitive Determination of Hepatitis B Antigen

Chemiluminescent Optical Fiber Immunosensor Combining Surface Modification and Signal Amplification for Ultrasensitive Determination of Hepatitis B Antigen

Optical fiber based immunosensors are very attractive for biomarker detection. In order to improve the sensor response, we propose a promising strategy which combines porous-layer modification of the fiber surface and streptavidin-biotin-peroxidase nano-complex signal amplification in chemiluminesce...

Full description

Bibliographic Details
Main Authors:	Xuexue Xu, Rongbin Nie, Jingwen Huang, Li Yang
Format:	Article
Language:	English
Published:	MDPI AG 2020-08-01
Series:	Sensors
Subjects:	optical fiber immunosensor surface modification signal amplification hepatitis B surface antigen hepatitis B e antigen
Online Access:	https://www.mdpi.com/1424-8220/20/17/4912

Similar Items

Genetic variation and significance of hepatitis B surface antigen
by: ZHANG Zhenhua
Published: (2013-11-01)

Clinical features of chronic hepatitis B patients with low hepatitis B surface antigen levels and determinants of hepatitis B surface antigen seroclearance
by: Hideaki Taniguchi, et al.
Published: (2020-08-01)

Dynamic Characteristics of Serum Hepatitis B Surface Antigen in Chinese Chronic Hepatitis B Patients Receiving 7 Years of Entecavir Therapy
by: Xia-Xia Zhang, et al.
Published: (2016-01-01)

Comparison of Two Enzyme Immunoassays for the Detection of Antibody to Hepatitis B Virus Core Antigen
by: Souto FJD, et al.
Published: (1997-01-01)

Baseline hepatitis B surface antigen quantitation can predict virologic response in entecavir-treated chronic hepatitis B patients
by: Chia-Chi Wang, et al.
Published: (2014-11-01)

Positive hepatitis B surface antigen after vaccination in a newborn
by: Mariana Martins, et al.
Published: (2018-07-01)

Hepatitis B Core-Related Antigen is a Biomarker for off-Treatment Relapse After Long-Term Nucleos(t)ide Analog Therapy in Patients with Chronic Hepatitis B
by: Liao G, et al.
Published: (2021-08-01)

Clinical performance of a new hepatitis B surface antigen quantitative assay with automatic dilution
by: Ta-Wei Liu, et al.
Published: (2015-01-01)

A Label-Free Immunosensor Based on Graphene Oxide/Fe<sub>3</sub>O<sub>4</sub>/Prussian Blue Nanocomposites for the Electrochemical Determination of HBsAg
by: Shanshan Wei, et al.
Published: (2020-03-01)

Use of quantitative hepatitis B surface antigen levels in the follow-up of HBV-Infected patients with Genotype D
by: Ergenekon Karagoz, et al.
Published: (2018-09-01)

Negative Correlation of Serum Hepatitis B Surface Antigen and Hepatitis B e Antigen Levels with the Severity of Liver Inflammation in Treatment-naïve Patients with Chronic Hepatitis B Virus Infection
by: Lu Zhang, et al.
Published: (2017-01-01)

Molecular and serological characterization of hepatitis B vaccine breakthrough infections in serial samples from two plasma donors
by: Mary C. Kuhns, et al.
Published: (2019-04-01)

Hepatitis B surface antigen variants in voluntary blood donors in Nanjing, China
by: Yong-lin Yang, et al.
Published: (2012-04-01)

Factors related to duration of serum HBsAg in patients with acute hepatitis B
by: ZHANG Jiawei
Published: (2014-11-01)

Hepatocellular Carcinoma in Hepatitis B Virus-Infected Patients and the Role of Hepatitis B Surface Antigen (HBsAg)
by: Catana, A.M, et al.
Published: (2022)

Hepatitis B surface antigen reduction as a result of switching from long‐term entecavir administration to tenofovir
by: Nobuharu Tamaki, et al.
Published: (2020-06-01)

Hepatitis B surface antigen quantification at hepatitis B e antigen seroconversion predicts virological relapse after the cessation of entecavir treatment in hepatitis B e antigen-positive patients
by: Yuan-wang Qiu, et al.
Published: (2016-02-01)

Immunogenicity, reactogenicity, and safety of a human rotavirus vaccine, Rotarix, in Taiwanese infants who received a dose of hepatitis B immunoglobulin after birth
by: Chun-Yi Lu, et al.
Published: (2013-09-01)

Comparison of the elecsys HBsAg II assay and the architect assay for quantification of hepatitis B surface antigen in chronic hepatitis B patients
by: Chen-Chih Liao, et al.
Published: (2015-06-01)

Prevalence of Hepatitis B Virus Among Pregnant Women on Antenatal Care Follow-Up at Mizan-Tepi University Teaching Hospital and Mizan Health Center, Southwest Ethiopia
by: Asaye Z, et al.
Published: (2021-01-01)

The Study of Frequency of HBS. Ag Positive cases in Voluntary Blood Donors in Hamadan Province from Feb. 95 to Jan. 96
by: Masoud Saboori Ghannad, et al.
Published: (1997-09-01)

Current diagnosis of occult or cryptic hepatitis B
by: João Renato Rebello Pinho
Published: (2005-03-01)

Nuclear Expression of Hepatitis B Virus X Protein Is Associated with Recurrence of Early-Stage Hepatocellular Carcinomas: Role of Viral Protein in Tumor Recurrence
by: Jing Jin, et al.
Published: (2016-05-01)

SEROPREVALENCE OF HEPATITIS-B VIRUS IN MID AND FAR WESTERN REGION IN NEPAL
by: Khan S, et al.
Published: (2013-01-01)

HBV感染者HBsAg和抗-HBs双阳性发生机制
by: REN Meixin
Published: (2014-04-01)

Hepatitis B surface antigen titer is a good indicator of durable viral response after entecavir off-treatment for chronic hepatitis B
by: Han Ah Lee, et al.
Published: (2016-09-01)

Middle-aged Subjects With Habitual Low-speed Cycling Exercise Have Greater Mononuclear Cell Responsiveness Against Human Hepatitis B Virus Surface Antigen
by: Kuen-Chang Hsieh, et al.
Published: (2010-06-01)

Symposium on HIV Variants and Hepatitis B Surface Antigen Mutants
by: Gerald G. Schochetman, et al.
Published: (2005-10-01)

Changes in the Hepatitis B Surface Antigen Level According to the HBeAg Status and Drug Used in Long-term Nucleos(t)ide Analog-treated Chronic Hepatitis B Patients
by: Jong Hwa Na, et al.
Published: (2021-06-01)

Hepatitis B surface antigen levels at 6 months after treatment can predict the efficacy of lamivudine-adefovir combination therapy in patients with lamivudine-resistant chronic hepatitis B
by: Jeong Han Kim, et al.
Published: (2014-09-01)

Changing serum levels of quantitative hepatitis B surface antigen and hepatitis B virus DNA in hepatitis B virus surface antigen carriers: A follow-up study of an elderly cohort
by: Yuan-Hung Kuo, et al.
Published: (2015-02-01)

Seroprevalence of hepatitis B surface antigen and its correlation with risk factors among new recruits in Turkey
by: Tulin Altay, et al.

Determination of Relative Frequency of HBS Ag, HCV and HIV Antibodies Serum Markers among Admitted Intravenous Drug Users in Infectious Disease Ward of Razi Hospital in Ahvaz, 2004-2005
by: Abdolrasool Nikkhooy, et al.
Published: (2012-07-01)

Change in HBsAg quantification after HBV DNA negative conversion in chronic hepatitis B patients treated with nucleos(t)ide analogues
by: ZHOU Youqian, et al.
Published: (2019-05-01)

HBS Ag seroclearance and seroconversion time in patients with chronic hepatitis B infection
by: jila Masrour-Roudsari, et al.
Published: (2020-03-01)

Seroprevalence of hepatitis B infection and associated risk factors among drug users in drop-in centers of Isfahan, Iran
by: Roya Taleban, et al.
Published: (2018-01-01)

Sero-prevalence of Hepatitis B virus surface antigen and associated factors among women of reproductive age in Bench Maji Zone, Southwest Ethiopia: Community based cross-sectional study
by: Abateneh, D.D, et al.
Published: (2022)

Detection of hepatitis B virus in clinically suspected infectious hepatitis pregnant and non-pregnant women
by: Salman Khan
Published: (2017-08-01)

Hepatitis B virus exposure in human immunodeficiency virus seropositive Cuban patients
by: Licel Rodríguez, et al.
Published: (2000-04-01)

Clinical, laboratory, and virological characteristics of patients with positive hepatitis B surface antigen in Upper Egypt
by: Khairy H Morsy, et al.
Published: (2015-01-01)